C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61P 7/00 (2006.01) C07D 401/14 (2006.01) C07D 409/14 (2006.01) C07D 417/06 (2006.01)
Patent
CA 2563401
The invention relates to compounds of formula (I), which are inhibitors of the activated thrombin-activatable fibrinolysis inhibitor. The compounds of formula (I) are suited for producing medicaments for the prevention and treatment of diseases accompanied by thromboses, embolisms, hypercoagulability or fibrotic changes.
La présente invention concerne des composés de formule (I) qui sont des inhibiteurs de l'inhibiteur de fibrinolyse pouvant être activé par thrombine activée. Ces composés de formule (I) conviennent à la production de médicaments pour prévenir et traiter des maladies qui sont accompagnées par des thromboses, des embolies, une hypercoagulabilité ou des modifications fibreuses.
Grueneberg Sven
Heitsch Holger
Kallus Christopher
Lindenschmidt Andreas
Szillat Hauke
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sanofi-Aventis Deutschland Gmbh
LandOfFree
Imidazole derivatives used as tafia inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives used as tafia inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives used as tafia inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1427927